Natalie Holles, Astellas

Astel­las fol­lows up $3B gene ther­a­py buy­out with $109M plan to ac­cel­er­ate a man­u­fac­tur­ing boom

Just weeks af­ter clos­ing on their $3 bil­lion Au­dentes buy­out, Astel­las is fol­low­ing up with a $109 mil­lion plan to build a new man­u­fac­tur­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.